ANAB

ANAPTYSBIO INC

ANAB·032724106·US·Common Stock·Healthcare - Biotechnology-13D/G

ANAB (ANAPTYSBIO INC) is held by 113 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($93.2M), MORGAN STANLEY ($55.1M), STATE STREET CORP ($55M). Net institutional sentiment: Mixed.

113
Holders
Avg rating(22 Elite)
$765.5M
Total Value
54% (119)
Fund Consensus
60 buying - 51 selling
ANABSmart Money Verdict
View all
Held by 113 funds
22 elite
Who's Trading
ActivistSISirenia Capital Management LP6.7%May 15, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.2%May 15, 2026
InsiderSPSchmid John P.Sell $702KMar 30, 2026
InsiderSPSchmid John P.Sell $427KMar 30, 2026
InsiderSPSchmid John P.Sell $30KMar 30, 2026
InsiderFDFaga DanielSell $29KMar 27, 2026
InsiderFDFaga DanielSell $149KMar 27, 2026
InsiderFDFaga DanielSell $215KMar 27, 2026
InsiderFDFaga DanielSell $29KMar 27, 2026
InsiderFDFaga DanielSell $33KMar 27, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
1.7M(-3.1%)$93.2M0.0%+393.08%
0
Decreased
993,905(-3.9%)$55.1M0.0%+197.80%
0
Decreased
992,445(-5.8%)$55M0.0%+170.00%
0
New
853,151$47.3M0.0%+25.67%
40
Decreased
579,296(-13.6%)$32.1M0.0%+88.47%
0
Increased
520,241(+10.8%)$28.9M0.0%+55.07%
32
New
519,870$28.8M0.0%+25.67%
40
Increased
501,086(+283.2%)$27.8M0.0%+50.30%
46
Decreased
492,120(-12.1%)$27.3M0.0%+110.79%
0
Decreased
475,572(-41.5%)$26.4M0.0%+186.32%
0
Increased
472,704(+1643.8%)$26.2M0.0%+31.31%
46
Increased
465,083(+81.2%)$25.8M0.0%+87.97%
44
Increased
364,121(+21.6%)$20.2M0.0%+84.47%
34
Decreased
344,256(-31.3%)$19.1M0.1%+187.82%
0
Decreased
332,743(-16.6%)$18.5M0.0%+223.17%
0
Decreased
316,065(-0.2%)$17.5M0.0%+202.79%
0
Increased
267,703(+66.5%)$14.8M0.0%+52.54%
41
Increased
254,736(+133.8%)$14.1M0.0%+30.53%
45
Increased
233,450(+113.2%)$12.9M0.0%+38.78%
45
Decreased
192,687(-3.0%)$10.7M0.0%+58.06%
0

Showing 1-20 of 119

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used